Company news
Anixa Biosciences, Inc. news in 2023
Anixa Biosciences, Inc.'s news releases, calls and decks from 2023, newest first.
Anixa Biosciences to Present at Biotech Showcase 2024
December 13, 2023
Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
December 5, 2023
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
December 5, 2023
Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
November 26, 2023
Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference
October 30, 2023
Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board
October 22, 2023
Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial
October 12, 2023
Anixa Biosciences Establishes Cancer Business Advisory Board
September 18, 2023
Anixa Biosciences to Participate in September Investor Conferences
August 30, 2023
Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial
August 27, 2023
Anixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical Trial
August 6, 2023
Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology
July 26, 2023
Anixa Biosciences Announces Issuance of Canadian Patent for its CAR-T Cancer Therapy Technology
July 10, 2023
Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial
May 21, 2023
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting
March 26, 2023
Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology
February 26, 2023
Anixa Biosciences Announces Formation of Breast Cancer Clinical Advisory Board
February 20, 2023
Decks in 2023
- Investor Presentation (March 2023)
Investor deck · 22 slides · Mar 10, 2023